Egypt's Ministry of Health aims to produce 140 million human vaccine doses annually by 2030 under its Vaccine City project. Health Minister Khaled Abdel Ghaffar reviewed the project's progress, emphasizing efforts for self-sufficiency and exports to regional and international markets.
Egypt's Ministry of Health issued a statement detailing the Vaccine City project, which spans 115,000 square metres across 32 buildings and facilities. The first phase is complete, with infrastructure works at about 90%, including three human vaccine factories, three veterinary vaccine factories, advanced research and development labs, and a logistics hub for storage and distribution.
Health Minister Khaled Abdel Ghaffar said the project "would enhance domestic manufacturing capabilities, support self-sufficiency, and position Egypt as an export hub supplying vaccines to more than 60 countries." The meeting also covered expanding cooperation with African countries and strengthening international biotechnology partnerships.
Egypt plans to scale production to 690 million human doses and 11 billion veterinary doses annually by 2040, meeting around 16% of Africa's vaccine demand. Officials reviewed the planned VBC Academy, a regional hub for training specialists in vaccine manufacturing and biotechnology, linking scientific research to industrial applications.
The initiative marks a strategic step toward an independent pharmaceutical base and bolstering public health systems nationally and continent-wide.